Slate Bio

Charlottesville, VA · Founded 2020 · Privately Held (backing)

Developer of a therapeutic platform intended to offer immunotherapeutics to resist autoimmune and inflammatory diseases. Slate Bio is based in Charlottesville, VA and was founded in 2020. It was valued at $11.3 million at its seed round in May 2023, the last priced event on record. It has raised $6 million across 2 recorded rounds; the latest was a $2.8 million seed round in Dec 2022.

PMV mark · valuation
$11.3M
Oct 2026
Priced at
its seed round
May 2023
Total raised
$6.0M
Last round
Seed Round
Dec 2022
How much has Slate Bio raised?
$6.0Macross 2 recorded rounds · Dec 2020 – Dec 2022

Most recently, Slate Bio raised $2.8M in its Seed Round (Dec 2022).

Free account
More of Slate Bio with a free account
  • ·Watch Slate Bio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Slate Bio round by round

2 rounds
Dec 2022Seed Round$2.8MSEC filing▮
9 investors participated
Dec 2020Seed Round$2.0MSEC filing▮
10 investors participated

How much has Slate Bio raised?

Slate Bio has raised $6 million in total; 2 of its rounds are on record. The largest on record was a $2.8 million seed round in Dec 2022.

Slate Bio has filed 3 Form Ds with the SEC since 2021, most recently in May 2023 ($2.8 million sold to 9 investors).

Slate Bio investors

8 investors are on record for Slate Bio, including Virginia Innovation Partnership Corporation, Virginia Venture Partners, CAV Angels and University of Virginia. The seed round in Dec 2022 drew 9 investors.

For fundraisers
Raising for a company like Slate Bio?

8 investors have backed Slate Bio.

See all 8 investors →

Frequently asked about Slate Bio

How much has Slate Bio raised?
Slate Bio has raised $6.0M in total across 2 recorded funding rounds.
When was Slate Bio's last funding round?
Slate Bio's most recent recorded round was Seed Round in Dec 2022, raising $2.8M.